Experimental models of the human brain are needed for basic understanding of its development and disease 1 . Human brain organoids hold unprecedented promise for this purpose; however, they are plagued by high organoid-to-organoid variability 2,3 . This has raised doubts as to whether developmental processes of the human brain can occur outside the context of embryogenesis with a degree of reproducibility that is comparable to the endogenous tissue. Here we show that an organoid model of the dorsal forebrain can reliably generate a rich diversity of cell types appropriate for the human cerebral cortex. We performed single-cell RNAsequencing analysis of 166,242 cells isolated from 21 individual organoids, finding that 95% of the organoids generate a virtually indistinguishable compendium of cell types, following similar developmental trajectories and with a degree of organoid-toorganoid variability comparable to that of individual endogenous brains. Furthermore, organoids derived from different stem cell lines show consistent reproducibility in the cell types produced. The data demonstrate that reproducible development of the complex cellular diversity of the central nervous system does not require the context of the embryo, and that establishment of terminal cell identity is a highly constrained process that can emerge from diverse stem cell origins and growth environments.
1
. It is unclear, however, whether the same reproducibility is achievable outside the embryo.
Previous work has shown that a large variety of cell types characteristic of defined brain regions, including the cerebral cortex, can be generated in vitro in human brain organoid and spheroid models derived from pluripotent stem cells [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . However, few studies have attempted to quantify cellular composition across individual organoids, limiting our understanding of the degrees of reproducibility achievable in different organoid models.
Therefore, we established four distinct protocols for producing 3D brain organoids and spheroids: self-patterned whole-brain organoids 3 ; patterned dorsal forebrain organoids (modified from ref.
5
); and patterned dorsal and ventral spheroids (modified from ref.
15
). We adapted each protocol to growth in spinner-flask bioreactors over durations of at least six months, to achieve advanced maturation (Extended Data Fig. 1a ; see Methods for details on protocol modifications).
To standardize and compare these four models, we derived cultures of each from the same human induced pluripotent stem (iPS) cell line, PGP1 16 . We observed substantial differences in overall external morphology and size across models (Extended Data Fig. 1a ). Self-patterned whole-brain organoids showed the greatest variability in shape. The two patterned spheroid models showed more consistent shape but remained substantially smaller. The dorsally patterned organoid model, however, showed desirable features of large size and consistent overall shape (Fig. 1a, b and Extended Data Fig. 1a ). For this model, we modified a previously published protocol 5 to eliminate the need for interventions to reduce hypoxia by adapting the cultures to growth in spinner-flask bioreactors (Fig. 1a) , enabling us to substantially extend development in vitro. Immunohistochemistry for the dorsal forebrain progenitor markers EMX1 and PAX6 and for the early pan-neuronal marker MAP2 confirmed the presence of rosette-like structures at one month, when dorsalized progenitors lined ventricle-like cavities (Fig. 1c) . The cortical pyramidal neuron subtype markers CTIP2 and SATB2 were expressed by two months and subsequently maintained (Fig. 1c and Extended Data Fig. 1b) . Notably, we observed these features in the majority of organoids across five distinct stem cell lines: PGP1 (male, human iPS cells; three independent experimental batches), HUES66 (female, human embryonic stem cells; two independent batches), GM08330 (male, human iPS cells), 11a (male, human iPS cells) and Mito 210 (male, human iPS cells). Across all lines, 100% of organoids expressed PAX6 and MAP2 at one, three and six months, and 89% also expressed EMX1 (Extended Data Table 1 ). On the basis of these promising features, we concentrated further analysis on the dorsally patterned organoid model.
We initially performed high-throughput single-cell RNA-sequencing (scRNA-seq) analysis on 78,379 cells from nine individual organoids from two stem cell lines, PGP1 (two independent batches, b1 and b2) and HUES66 (one batch), at three months of growth (Fig. 1d) . For each batch, we clustered cells from all organoids and systematically classified the clusters by comparing signatures of differentially expressed genes (Supplementary Table 1 , Supplementary Note 1) to pre-existing datasets of endogenous cell types 3, 8, [17] [18] [19] [20] [21] [22] [23] (examples in Extended Data Fig. 2a ). This defined eleven main transcriptionally distinct cell types across both lines, representing a large diversity of progenitor and neuronal cell types appropriate for the cerebral cortex (Fig. 1d) .
To determine whether each organoid had generated the complete set of cells, we aligned and co-clustered the cells from all nine organoids (Fig. 1d) . We found that organoids were highly reproducible in cellular composition across different lines and batches (Fig. 1d) . Furthermore, the cell-type assignments from the batch-by-batch analysis were grouped together by the co-clustering analysis, indicating consistent transcriptional signatures for individual cell types across lines and batches. Although one organoid (Org 4) had an increased number of corticofugal projection neurons, the overall proportions of individual cell types were consistent across cell lines (see also Extended Data Fig. 5a ). Expression of cell-type-specific markers assayed by immunohistochemistry and RNA in situ hybridization showed equally high consistency (Extended Data Fig. 2b-d ). These organoids not only produce a large variety of cortical cell types, but cell identity and diversity are reproducible across individual organoids and experiments.
Cellular diversity of the cerebral cortex develops in a specific temporal sequence Letter reSeArCH development, were notably under-represented in the three-month cultures. Therefore, we grew organoids from the PGP1, GM08330 and 11a stem cell lines for six months and performed scRNA-seq of an additional 87,863 cells from 12 individual organoids (PGP1: two independent batches, b1 and b3; GM08330 and 11a: one batch each) (Fig. 2a) . One out of the 12 organoids did not show expression of FOXG1 or any other neuronal marker, suggesting that differentiation had stalled at an early stage. We thus excluded this organoid from further analysis. Co-clustering of all cells in the remaining 11 organoids identified thirteen main cell classes (Fig. 2a) . Notably, organoid-to-organoid variability remained extremely low even after six months of culture.
To quantify changes in cellular composition over time, we combined and co-clustered cells from organoids derived from the same differentiation batch (PGP1 b1) but collected at three and six months (Fig. 2b) . The six-month cultures contained substantial numbers of astrocytes, confirmed by immunohistochemistry for the astrocytic markers S100B and GFAP (Fig. 2c) , as well as cycling inhibitory interneuron precursors and immature inhibitory interneurons (Fig. 2a, b) . Whereas the origin of these interneurons is unclear, their transcriptional similarity to intermediate progenitor cells (see also Extended Data Fig. 4b ) suggests that they could be interneurons of the olfactory bulb, which originate from subventricular zone progenitors 25 . The data indicate that appropriate additional cell types develop in these organoids, respecting endogenous temporal sequences. Despite the long culture period, molecular markers of apoptosis and hypoxia remained low (Extended Data Fig. 3a-e) .
It is possible that, within individual organoids, the same terminal composition of cell types may be generated via distinct developmental trajectories. To address this question, we calculated a developmental pseudotime trajectory 26 across all cell lines for each time point. Each organoid distributed similarly along the pseudotime trajectory, independent of line or batch, and the pseudotemporal ordering of cell types approximated that of in vivo human development (Fig. 3a, b and Extended Data Fig. 4a ). At three months, all organoids followed a trajectory that progressed from radial glia to mature excitatory neurons. Confirming neuronal maturation, co-localization of the pre-and post-synaptic markers VGLUT1 and PSD95 suggested the presence of excitatory synapses at this time point (Fig. 3c) . At six months, Letter reSeArCH the trajectory proceeded along two branches-towards excitatory neurons or mature astrocytes. The data show that beyond terminal cellular composition, developmental trajectories of fate specification are reproducibly established in each organoid and can therefore be reliably investigated in this system. To assess similarity between organoid cell types and those of the endogenous human brain, we used a published scRNA-seq dataset of human fetal cerebral cortex 18 . In brief, fetal human cells were used to train a random forest classifier, which was then applied to assign organoid cells to the human cortex cell categories 27 . Organoid cells at both three and six months were predominantly assigned to the corresponding endogenous cell class, indicating that their transcriptional profiles were similar to endogenous cells ( Fig. 3d and Extended Data Fig. 4b ).
It is unclear whether treatment with exogenous patterning signals could negatively affect the fidelity of terminal cell identities compared to cells made in self-organizing models. Therefore, we investigated whether transcriptional similarity to endogenous human fetal cortex 18 cells was comparable to that found in self-patterned whole-brain organoids analysed in our previous study 3 (see Methods). All of the dorsally patterned organoids and the whole-brain organoids showed similarly high correlation with human cells (correlation coefficients between 0.67 and 0.80; Fig. 3e) . Therefore, the use of exogenous patterning signals in this model does not require a trade-off in the fidelity of the cell types generated. Of note, the main cell types present in organoids at three months are as similar to the corresponding endogenous cells as those present at six months, suggesting that by three months organoids are already a valuable tool for modelling human neurodevelopmental processes.
To evaluate the reproducibility of this model relative to previously studied systems, we compared the variability of dorsally patterned forebrain organoids and self-patterned whole-brain organoids 3 (Extended Data Fig. 5a, b) . scRNA-seq data for the 19 individual self-patterned whole-brain organoids in our previous study 3 showed high organoid-to-organoid variability, with only a minority of organoids (4/19) generating substantial amounts of forebrain cells (Extended Data Fig. 5b ). We applied intraclass correlation (ICC)-a correlation metric Letter reSeArCH that considers group structure in the data (that is, cell types)-to the proportions of each cell type produced by each organoid; an ICC near 1.0 indicates high agreement. The 19 organoids in the whole-brain organoid cohort had an ICC of 0.39 (95% confidence interval (CI), 0.23-0.65). By contrast, the pre-patterned organoids of the present study scored much higher (three-month organoids: ICC, 0.85; 95% CI, 0.69-0.96; six-month organoids: ICC 0.68, 95% CI, 0.45-0.89) (Extended Data Fig. 5a ).
The availability of scRNA-seq datasets from multiple individual human 28, 29 and mouse 30 cortices allowed us to investigate whether the reproducibility of cell types generated in dorsally patterned organoids was similar to that between individual endogenous brains. As existing datasets vary in the terminology and degree of granularity used for cell-type assignment (Extended Data Fig. 5 ), we first reclustered each dataset using identical methods. We calculated mutual information (MI) scores between cluster assignments and sample identity in each dataset ( Fig. 4a-e) ; a lower MI score and lower z-score indicate higher reproducibility between individuals. For the self-patterned whole-brain organoid model 3 , we examined specifically the best-performing batch of four organoids that produced forebrain cells; these organoids had a high MI score of 0.27 and a z-score of 156.4 (Fig. 4b) . Conversely, in the dorsally patterned organoids, reproducibility was consistently high, as reflected in low MI and z-scores (MI, 0.049-0.089; z-score, 38.0-75.7) (Fig. 4a) . Notably, the reproducibility with which the different clusters are generated in individual dorsally patterned organoids ( Fig. 4a and Extended Data Fig. 5a ) is comparable to that of individual endogenous human or mouse brain samples (MI range, 0.008-0.064; z-score range 2.2-41.4) . All datasets, including the human and mouse endogenous brains, showed variation between samples; however, the degree of variation in the dorsally patterned organoid samples was similar to that of the endogenous-brain datasets.
Stem cell-based models of the human brain offer an opportunity to investigate processes of human brain development and disease that would not otherwise be experimentally accessible. However, their application has been limited by a variety of factors-prominent among them is the lack of developmental reproducibility between individual organoids. Here, using a large scRNA-seq dataset in brain organoids, we demonstrate that the extensive cellular diversity of a complex central nervous system region can be generated outside of the embryo in a highly reproducible and developmentally constrained manner that transcends individual organoids, experimental batch, genetic background and sex. These data suggest that dynamic processes of development can be modelled in organoids, and that early patterning of a brain region starts a process of cell specification and maturation that is highly constrained even outside the embryo. This level of reproducibility in vitro informs us about basic constraints and principles that control cell diversification in the human brain, and establishes a 
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Methods
Data reporting.
No statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. Pluripotent stem cell culture. The PGP1 (Personal Genome Project 1) human iPS cell line was from the laboratory of G. Church
16
; the HUES66 hESC and the 11a human iPS cell lines were from the Harvard Stem Cell Institute; the GM08330 human iPS cell line 31 (also known as GM8330-8) 32 was from the laboratory of M. Talkowski (MGH Hospital); and the Mito 210 human iPS cell line was from the laboratory of B. Cohen (McLean Hospital). All pluripotent stem cell lines were cultured in feeder-free conditions on Geltrex (Gibco)-coated cell culture dishes, using mTESR1 medium (Stem Cell Technologies) with 100 U/ml penicillin and 100 μg/ml streptomycin (Corning), at 37 °C in 5% CO 2 . All human pluripotent stem cells were maintained below passage 50, were negative for mycoplasma (assayed with the MycoAlert PLUS Mycoplasma Detection Kit, Lonza), and karyotypically normal (G-banded karyotype test, performed by WiCell Research Institute). The PGP1 and HUES66 lines were authenticated using STR analysis completed by TRIPath (2018) and GlobalStem (2008), respectively. For authentication of the 11a cell line, refer to ref.
3
. The GM08330 line was not authenticated. The Mito 210 line was authenticated by genotyping analysis (Fluidigm FPV5 chip) performed by the Broad Institute Genomics Platform (2017). All experiments involving human cells were approved by the Harvard University IRB and ESCRO committees. Organoid differentiation. To generate dorsally patterned forebrain organoids, we modified the method previously described in ref.
5
. We eliminated the need for growth under 40% O 2 , the need for cell aggregates to be periodically bisected and the use of high-O 2 -penetration dishes, by adapting the cultures to growth in spinner-flask bioreactors. Specifically, on day 0, feeder-free cultured human pluripotent stem cells, 80-90% confluent, were dissociated to single cells with Accutase (Gibco), and 9,000 cells per well were reaggregated in ultra-low-celladhesion 96-well plates with V-bottomed conical wells (sBio PrimeSurface plate; Sumitomo Bakelite) in cortical differentiation medium (CDM) I, containing Glasgow-MEM (Gibco), 20% Knockout Serum Replacement (KSR) (Gibco), 0.1 mM Minimum Essential Medium non-essential amino acids (MEM-NEAA) (Gibco), 1 mM pyruvate (Gibco), 0.1 mM 2-mercaptoethanol (Gibco), 100 U/ml penicillin and 100 μg/ml streptomycin (Corning). From day 0 to day 6, ROCK inhibitor Y-27632 (Millipore) was added to the medium at a final concentration of 20 μM. From day 0 to day 18, WNT inhibitor IWR1 (Calbiochem) and TGFβ inhibitor SB431542 (Stem Cell Technologies) were added at a concentration of 3 μM and 5 μM, respectively. From day 18, the floating aggregates were cultured in 100-mm ultra-low-attachment culture dishes (Corning) under orbital agitation (70 r.p.m.) in CDM II, containing DMEM/F12 medium (Gibco), 2 mM Glutamax (Gibco), 1% N 2 (Gibco), 1% Chemically Defined Lipid Concentrate (Gibco), 0.25 μg/ml fungizone (Gibco), 100 U/ml penicillin and 100 μg/ml streptomycin. On day 35, cell aggregates were transferred to spinner-flask bioreactors (Corning) and maintained at 56 r.p.m., in CDM III, consisting of CDM II supplemented with 10% fetal bovine serum (FBS) (GE-Healthcare), 5 μg/ml heparin (Sigma) and 1% Matrigel (Corning). From day 70, organoids were cultured in CDM IV, consisting of CDM III supplemented with B27 supplement (Gibco) and 2% Matrigel. A stepby-step protocol describing the long-term culture of dorsally patterned forebrain organoids is available at Protocol Exchange 33 . Over the time course of the differentiations (experimental batches) included in this paper, an estimated 13 batches of FBS, 4 batches of KSR and 23 batches of Matrigel were used.
We observed that when starting with healthy viable human iPS cells (mycoplasma-free, karyotypically normal and below passage 50) with typical morphological features of undifferentiated cells (tightly packed colonies of round cells with large nuclei and nucleoli) at 80-90% confluency, the efficiency of forebrain cell-type generation was ~90% (93/103 organoids, scRNA-seq and immunohistochemistry combined efficiency, Extended Data Table 1) .
Self-patterned whole-brain organoids were generated as previously described 3, 34 . Dorsal and ventral spheroids were generated using a modification of a previously described protocol 15 . Specifically, spheres of pluripotent stem cells were grown for four additional days before neural induction; for ventral spheroids, specification of ventral telencephalic identity was obtained by treatment with the SHH agonist SAG (Selleckhem; 100 nM) from days 7 to 20. Immunohistochemistry and in situ hybridization. Samples were fixed in 4% paraformaldehyde (Electron Microscopy Services), cryoprotected in 30% sucrose solution, embedded in optimum cutting temperature (OCT) compound (Tissue Tek) and cryosectioned (14-μm thickness). Sections were washed with 0.1% Tween-20 (Sigma) in phosphate buffered saline (PBS) (Gibco), blocked for 1 h at room temperature with 6% donkey serum (Sigma) and 0.3% Triton X-100 (Sigma) in PBS, and incubated with primary antibodies overnight at 4 °C (diluted with 2.5% donkey serum + 0.1% Triton X-100 in PBS). Primary antibodies and dilutions used are specified in Extended Data Table 2 . PSD95 and VGLUT1 immunohistochemistry was performed as described 20 . RNA in situ hybridization was performed using the RNAscope Fluorescent Multiplex Reagent Kit (Advanced Cell Diagnostics) according to the manufacturer's instructions. The probes used are: Hs-EOMES-C2 (429691-C2), Hs-TBR1-C3 (425571-C3), and Hs-Reln (413051) (Advanced Cell Diagnostics). Microscopy and image analysis. Images of organoids in culture were taken on an EVOS FL microscope (Invitrogen). Immunofluorescence images were acquired with a Nikon Eclipse 90i microscope and analysed with Volocity 4.1 software. Confocal images were obtained using an LSM 700 inverted confocal microscope (Zeiss) and analysed with the Zen Blue/Black 2012 image-processing software. Dissociation of brain organoids and single-cell RNA-seq. Individual brain organoids were dissociated into a single-cell suspension using the Worthington Papain Dissociation System kit (Worthington Biochemical). A detailed description of the dissociation protocol is available at Protocol Exchange 33 . Dissociated cells were resuspended in ice-cold PBS containing 0.04% BSA (Sigma) at a concentration of 1,000 cells/μl, and approximately 17,400 cells per channel (to give estimated recovery of 10,000 cells per channel) were loaded onto a Chromium Single Cell 3′ Chip (10x Genomics, PN-120236) and processed through the Chromium controller to generate single-cell gel beads in emulsion (GEMs). scRNA-seq libraries were prepared with the Chromium Single Cell 3′ Library & Gel Bead Kit v.2 (10x Genomics, PN-120237). Libraries from different samples were pooled based on molar concentrations and sequenced on a NextSeq 500 instrument (Illumina) with 26 bases for read 1, 57 bases for read 2 and 8 bases for index 1. After the first round of sequencing, libraries were re-pooled on the basis of the actual number of cells in each and re-sequenced to give an equal number of reads per cell in each sample and to reach a sequencing saturation of at least 50% (in most cases >70%). Single-cell RNA-seq data analysis. The Cell Ranger 2.0.1 pipeline 35 (10x Genomics) was used to align reads from RNA-seq to the GRCh38 human reference genome and produce the associated cell-by-gene count matrix (Extended Data Table 3 ). Default parameters were used, except for the '-cells' argument. Unique molecular identifier (UMI) counts were analysed using the Seurat R package v.2.3.4 36 . Cells expressing a minimum of 500 genes were kept, and UMI counts were normalized for each cell by the total expression, multiplied by 10 6 , and log-transformed. Seurat's default method for identifying variable genes was used with x.low.cutoff = 1, and the ScaleData function was used to regress out variation due to differences in total UMIs per cell. Principal component analysis (PCA) was performed on the scaled data for the variable genes, and top principal components were chosen. Cells were clustered in PCA space with a method adapted from ref.
27
by finding the 50 nearest neighbours to each cell using R's RANN package 37 , building a graph with edges between neighbour cells weighted by the Jaccard distance, and performing Louvain clustering on the resulting graph. Variation in the cells was visualized by t-SNE on the top principal components.
For each dataset of three organoids, differentially expressed genes that were upregulated in each cluster compared to the rest of the cells were identified using Seurat's implementation of the model-based analysis of single cell transcriptomics (MAST) algorithm 38 (Supplementary Table 1 ). To identify cell types, genes with a Bonferroni-adjusted P value less than 0.01 and a log fold change of at least 0.25 were taken into consideration. Ambient RNA was found to affect clustering distribution in at least two individual batches (Supplementary Note 1), but no correction was needed after comparing data across batches. To do so, we used Seurat's canonical correlation analysis (multi-CCA) procedure for batch correction with default parameters 36 . In brief, this identifies vectors along which the datasets correlate, and then aligns values along these vectors to reduce batch variation. t-SNE plots were used to visualize variation in the data after alignment in the top 20 canonical correlation vectors.
Pseudotime analysis was performed using the Monocle package v.2.99.1 26 with default parameters. UMI counts from 35,000 randomly sampled cells per time point were imported into Monocle's CellData Set object with an expected negative binomial distribution. t-SNE plots were used for visualization, and the 'SimplePPT' method was used to learn a tree-like trajectory between the cells. When ordering the cells along this trajectory, cells previously assigned to the 'cycling progenitors' cell type were specified as the starting state. Finally, Scrublet v.0.1 39 was used to assess the effect of droplets that may have contained more than one cell, with an expected doublet rate of 0.1 and a score threshold of 0.39, chosen based on histograms of simulated doublet scores (Extended Data Fig. 3f ).
Comparison to published single-cell RNA-seq data. To compare the cell types found in the dorsally patterned organoids to previously published data from whole-brain organoids 3 and endogenous tissue 18,28-30 , we downloaded UMI count data available from those publications, created Seurat objects, and submitted the data to the same normalization, clustering, and visualization pipeline as above. In the case of ref. 29 , log(TPM + 1) were used instead of UMI counts (TPM, transcripts per million). To compare variability in cell-type proportion between dorsally patterned organoids and whole-brain organoids, intraclass correlation was computed by creating a table of cell-type proportions across each individual organoid, and using the ICC command in the irr R package v0.84, with model = "twoway", type = "agreement", and unit = "single". To compare celltype classifications between organoid data and fetal human data (as in Fig. 3d and Extended Data Fig. 4b ), cell types as assigned to each cell in a previous study 18 were aggregated into more general cell types (after removing clusters not found in organoids: oligodendrocyte precursors, endothelial, and microglia; or with too few cells: unknown and astrocytes) and used to train a random forest classifier to distinguish between cell types 27 . This was done with the tuneRF function in the randomForest R package 40 with doBest = T, after the data were downsampled to 314 cells per cell type (the size of the smallest cell type). The classifier was then applied to the organoid data to assign organoid cells to one of the human cortex cell types. To calculate correlations between cell types (as in Fig. 3e ), we assigned cell types to cells in ref.
18 using the same method that was used for organoids. The Spearman correlation was calculated between the gene expression of highly variable genes in the ref.
18 dataset in the 'average cell' in each cell type (calculated with Seurat's AverageExpression function). To measure reproducibility of clusters per individual organoid, human cortex or mouse cortex sample, data were downsampled to have 659 cells per individual (to match the sample with the fewest cells, adult human cortex 5) before clustering all individuals in a dataset together. Mutual information was calculated between cluster assignments and individuals with the mpmi R package. z-scores were calculated by creating background distributions for each dataset, by permuting cluster assignments and re-calculating the mutual information score 1,000 times. The reference datasets used for comparison are available in the Gene Expression Omnibus with accession numbers GSE86153, GSE116470 and GSE103723 or at the Database of Genotypes and Phenotypes with accession numbers phs000989.v3 and phs000424.v8.p1. Statistics and reproducibility. A total of 21 single organoids collected at three and six months, derived from four different cell lines, from six independent batches (PGP1: three batches; HUES66, GM08330, and 11a: one batch each; n = 3 organoids per batch and time point) were profiled by scRNA-seq. Analysis of over 166,242 single cells revealed reproducibility in the diversity of cell types generated 'organoid-to-organoid' for 20/21 organoids (~95% efficiency) (Extended Data Table 1 ). A total of 82 single organoids, derived from five different lines, from eight independent batches (PGP1: three batches; HUES66: two batches; GM08330, 11a and Mito 210: one batch each) were analysed by immunohistochemistry for expression of EMX1, PAX6, MAP2 at one month (n = 26/26 positive); three months (n = 37/37 positive for PAX6 and MAP2; and 36/37 positive for EMX1); and six months (n = 19/19 positive for PAX6 and MAP2; 11/19 positive for EMX1) (Fig. 1c, Extended Data Fig. 2b and Extended Data Table 1 ). Immunohistochemistry for CTIP2 and SATB2 was performed on three-month organoids derived from five different cell lines, from eight independent batches (PGP1: three batches; HUES66: two batches; GM08330, 11a and Mito 210: one batch each) (n = 32/37 positive for CTIP2; n = 28/37 positive for SATB2) (Fig. 1c,  Extended Data Fig. 2b ). Immunohistochemistry for GFAP and S100B (Fig. 2c) was performed on six-month organoids derived from one cell line (PGP1, one batch) (n = 3/3 positive). Immunohistochemistry for VGLUT1 and PSD95 (Fig. 3c) was performed on three-month organoids from two cell lines, from two independent batches (PGP1 and 11a: one batch each) (n = 10/10 positive). Immunohistochemistry for SOX2 (Extended Data Fig. 2b ) was performed on three-month organoids from five cell lines, from seven batches (PGP1: two batches; HUES66: two batches; 11a, GM08330 and Mito210: one batch) (n = 34/34 positive). Immunohistochemistry for Ki67 (Extended Data Fig. 2b ) was performed on three-month organoids from four cell lines, from four batches (PGP1, 11a, HUES66 and GM08330: one batch each) (n = 22/22 positive). Immunohistochemistry for FOXG1, HOPX, TBR1 and TBR2 at three and six months (Extended Data Fig. 2d ) was performed on organoids from one cell line (PGP1: one batch) (n = 7/7 positive). Immunohistochemistry for HOPX at three months was also performed on two additional cell lines (HUES66 and GM08330: one batch each) (n = 12/12 positive). Immunohistochemistry for cleaved caspase 3 (Extended Data Fig. 3e ) was performed on organoids from one batch of the PGP1 cell line, at three, four, five and six months (n = 3 for each time point). Overall, expression of MAP2, EMX1, PAX6, CTIP2, and SATB2 was assessed at one, three and six months on organoids from each independent batch, and also at two, four and five months for one batch of PGP1 (Extended Data Fig. 1b) .
RNA in situ hybridization for EOMES (TBR2), Reelin and TBR1 was performed on three-month organoids from four cell lines (PGP1, 11a, GM08330 and HUES66), from four batches (n = 22/22 positive) (Extended Data Fig. 2c ).
Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
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Data analysis
For the single cell data, we used the publicly available Cell Ranger 2.0.1 pipeline (10X Genomics), the Seurat R package v2.3.4, Scrublet python package v0.1, and the Monocle R package v2.99.1 for analysis. Custom code used in conjunction with these packages for data analysis is available on GitHub at https://github.com/AmandaKedaigle/BrainOrganoidsReproducibility.
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